- |||||||||| levofloxacin / Generic mfg., prulifloxacin / Generic mfg.
Trial completion: A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control (clinicaltrials.gov) - Jul 16, 2015 P3, N=216, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| levofloxacin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Pharmacokinetics of Levofloxacin in Intensive Care Unit (clinicaltrials.gov) - Mar 7, 2015 P4, N=52, Completed, Trial primary completion date: Sep 2013 --> Dec 2017 Recruiting --> Completed | N=65 --> 52 | Trial primary completion date: Dec 2014 --> Sep 2014
- |||||||||| levofloxacin / Generic mfg.
Enrollment open, Trial initiation date, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Feb 5, 2015 P2, N=100, Recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Jan 2015
- |||||||||| loperamide / Generic mfg., azithromycin / Generic mfg.
Trial primary completion date: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea (clinicaltrials.gov) - Oct 10, 2014 P=N/A, N=510, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Apr 2015
- |||||||||| levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., duloxetine / Generic mfg.
Trial primary completion date: Rechallenge, Potential Drug Induced Liver Injury (Kaiser) (clinicaltrials.gov) - Jul 8, 2014 P=N/A, N=1, Completed, N=440 --> 600 Trial primary completion date: Feb 2014 --> Apr 2013
- |||||||||| Decadron (dexamethasone) / Merck (MSD), Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Enrollment change, Trial termination: Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach (clinicaltrials.gov) - Jul 8, 2014 P2, N=17, Terminated, Active, not recruiting --> Terminated; Low rate of accrual N=35 --> 17 | Active, not recruiting --> Terminated; Low rate of accrual
- |||||||||| levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., duloxetine / Generic mfg.
Trial completion, Trial primary completion date: Rechallenge, Potential Drug Induced Liver Injury (Kaiser) (clinicaltrials.gov) - Jul 8, 2014 P=N/A, N=1, Completed, N=35 --> 17 | Active, not recruiting --> Terminated; Low rate of accrual Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Apr 2013
|